These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12433488)

  • 1. Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site.
    Islam T; Butler M; Sikkander SA; Toida T; Linhardt RJ
    Carbohydr Res; 2002 Nov; 337(21-23):2239-43. PubMed ID: 12433488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of heparin fragments. A chemical synthesis of the pentasaccharide O-(2-deoxy-2-sulfamido-6-O-sulfo-alpha-D-glucopyranosyl)-(1-4 )-O-(beta-D-glucopyranosyluronic acid)-(1-4)-O-(2-deoxy-2-sulfamido-3,6-di-O-sulfo-alpha-D-glu copyranosyl)-(1-4)-O-(2-O-sulfo-alpha-L-idopyranosyluronic acid)-(1-4)-2-deoxy-2-sulfamido-6-O-sulfo-D-glucopyranose decasodium salt, a heparin fragment having high affinity for antithrombin III.
    Petitou M; Duchaussoy P; Lederman I; Choay J; Sinaÿ P; Jacquinet JC; Torri G
    Carbohydr Res; 1986 Mar; 147(2):221-36. PubMed ID: 3708627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention of antilipemic activity by periodate-oxidized non-anticoagulant heparins.
    Casu B; Diamantini G; Fedeli G; Mantovani M; Oreste P; Pescador R; Porta R; Prino G; Torri G; Zoppetti G
    Arzneimittelforschung; 1986 Apr; 36(4):637-42. PubMed ID: 3013215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin-catalyzed inactivation of factor Xa and thrombin by antithrombin III--effect of platelet factor 4.
    Schoen P; Lindhout T; Franssen J; Hemker HC
    Thromb Haemost; 1991 Oct; 66(4):435-41. PubMed ID: 1665594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources.
    Loganathan D; Wang HM; Mallis LM; Linhardt RJ
    Biochemistry; 1990 May; 29(18):4362-8. PubMed ID: 2350542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligosaccharide mapping of low molecular weight heparins: structure and activity differences.
    Linhardt RJ; Loganathan D; al-Hakim A; Wang HM; Walenga JM; Hoppensteadt D; Fareed J
    J Med Chem; 1990 Jun; 33(6):1639-45. PubMed ID: 2160537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H NMR spectroscopic studies on the interactions between human plasma antithrombin III and defined low molecular weight heparin fragments.
    Horne A; Gettins P
    Biochemistry; 1992 Mar; 31(8):2286-94. PubMed ID: 1311598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.
    Alekseeva A; Casu B; Cassinelli G; Guerrini M; Torri G; Naggi A
    Anal Bioanal Chem; 2014 Jan; 406(1):249-65. PubMed ID: 24253408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ratios of anti-factor Xa to antithrombin activities of heparins as determined in recalcified human plasma.
    Schoen P; Lindhout T; Hemker HC
    Br J Haematol; 1992 Jun; 81(2):255-62. PubMed ID: 1322691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the antithrombin-binding site in heparin.
    Lindahl U; Bäckström G; Höök M; Thunberg L; Fransson LA; Linker A
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3198-202. PubMed ID: 226960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and structural characterization of large heparin-derived oligosaccharides.
    Pervin A; Gallo C; Jandik KA; Han XJ; Linhardt RJ
    Glycobiology; 1995 Feb; 5(1):83-95. PubMed ID: 7772871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energetics of hydrogen bond switch, residue burial and cavity analysis reveals molecular basis of improved heparin binding to antithrombin.
    Singh P; Singh K; Jairajpuri MA
    J Biomol Struct Dyn; 2011 Oct; 29(2):339-50. PubMed ID: 21875153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of enoxaparin reducing end amino sugars to periodate oxidation.
    Alekseeva A; Elli S; Cosentino C; Torri G; Naggi A
    Carbohydr Res; 2014 Dec; 400():33-43. PubMed ID: 25457608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation.
    Maruyama T; Toida T; Imanari T; Yu G; Linhardt RJ
    Carbohydr Res; 1998 Jan; 306(1-2):35-43. PubMed ID: 9691438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.
    Toida T; Hileman RE; Smith AE; Vlahova PI; Linhardt RJ
    J Biol Chem; 1996 Dec; 271(50):32040-7. PubMed ID: 8943254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site.
    Cesaretti M; Luppi E; Maccari F; Volpi N
    Glycobiology; 2004 Dec; 14(12):1275-84. PubMed ID: 15253929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in the growth inhibition of bovine pulmonary artery smooth muscle cells by an O-hexanoyl low-molecular-weight heparin derivative.
    Garg HG; Hales CA; Yu L; Butler M; Islam T; Xie J; Linhardt RJ
    Carbohydr Res; 2006 Nov; 341(15):2607-12. PubMed ID: 16920092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.
    Li G; Yang B; Li L; Zhang F; Xue C; Linhardt RJ
    Anal Biochem; 2014 Jun; 455():3-9. PubMed ID: 24680753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies.
    Casu B; Oreste P; Torri G; Zoppetti G; Choay J; Lormeau JC; Petitou M; Sinäy P
    Biochem J; 1981 Sep; 197(3):599-609. PubMed ID: 7325974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4).
    Padilla A; Gray E; Pepper DS; Barrowcliffe TW
    Br J Haematol; 1992 Oct; 82(2):406-13. PubMed ID: 1329921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.